Bayer Cements Supplement Sales Gains From Initial COVID Boost
A year on from the start of the COVID-19 outbreak and a global rush for supplements, Bayer has cemented these sales gains with slight growth at its Nutritionals business in Q1.
You may also be interested in...
Bayer Consumer Health reported sales up in all categories and regions in the first quarter of 2022, with demand particularly high for dietary supplements and cough & cold products.
The first year of the pandemic saw a move among consumers towards prevention and wellness under the banner of "self-care". In 2021, the "self-care movement" really started to gain momentum as these new healthcare habits endured, and companies responded with more wellness options, in some cases even pivoting towards becoming pure self-care players.
Bayer believes its Consumer Health business has the potential to grow at twice the rate of the global market in 2021 following a double-digit rise in sales in the second quarter.